Contact Us

Diabetes Care Portfolio

DMS

  • Composition: (Each uncoated bilayered tablet contains)
    • Metformin Hydrochloride (SR) IP – 500 mg
    • Glimepiride IP – 1 mg
    • Voglibose IP – 0.2 mg
    • Excipients – qs.
  • Composition:(Each uncoated bilayered tablet contains)
    • Metformin Hydrochloride (SR) IP – 500 mg
    • Glimepiride IP – 2 mg
    • Voglibose IP – 0.3 mg
    • Excipients – qs.
  • Dosage:

    As directed by physician.

  • Indication:

    Type-2 diabetes.

  • Description:

    A triple drug therapy containing Metformin, Glimepiride and Voglibose. The advanced formulation enables BIOGNIDE GV1/GV2 to disintegrate faster as compared to another marketed brand that makes faster availability of drug at site of absorption. Small tablet size improves patient compliance.

Company

Connect with us on

Linkedin

Products

Quick Links

Connect With Us

©2021, All rights reserved, BioGenomics Limited.

Designed & Developed by W